• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎中组织浸润和循环CD68 +细胞的功能特征。该疾病两种成分的证据。

Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.

作者信息

Wagner A D, Goronzy J J, Weyand C M

机构信息

Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905.

出版信息

J Clin Invest. 1994 Sep;94(3):1134-40. doi: 10.1172/JCI117428.

DOI:10.1172/JCI117428
PMID:8083354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC295180/
Abstract

Macrophages represent a critical component in the inflammatory lesions of giant cell arteritis. By combining immunohistochemistry and in situ hybridization, we have analyzed the functional heterogeneity of tissue-infiltrating macrophages in patients with untreated vasculitis. 20% of macrophages in temporal artery tissue synthesized IL-6-specific mRNA and produced IL-6 and IL-1 beta proteins. IL-6 and IL-1 beta production was not limited to CD68+ cells in the lymphoid aggregates but was a feature of CD68+ cells dispersed throughout the tissue. 50% of tissue-infiltrating CD68+ cells synthesized 72-kD type IV collagenase. Only a small subset of CD68+ cells produced cytokines as well as collagenase, indicating functional specialization or distinct differentiation stages of CD68+ cells in the inflamed tissue. Activation of CD68+ cells was not restricted to tissue-infiltrating cells. Expression of IL-6 and IL-1 beta was found in 60-80% of circulating monocytes of patients with untreated giant cell arteritis, whereas collagenase production was restricted to tissue macrophages. IL-6 and IL-1 beta production by the majority of circulating monocytes was a shared feature of patients with giant cell arteritis and polymyalgia rheumatica but was not found in rheumatoid arthritis. These data suggest that giant cell arteritis has two components of disease, an inflammatory reaction in vessel walls and a systemic activation of monocytes. Systemic monocyte activation can manifest independently without vasculitis as exemplified in patients with polymyalgia rheumatica.

摘要

巨噬细胞是巨细胞动脉炎炎症病变中的关键组成部分。通过结合免疫组织化学和原位杂交技术,我们分析了未经治疗的血管炎患者组织浸润巨噬细胞的功能异质性。颞动脉组织中20%的巨噬细胞合成白细胞介素-6(IL-6)特异性信使核糖核酸(mRNA)并产生IL-6和白细胞介素-1β(IL-1β)蛋白。IL-6和IL-1β的产生并不局限于淋巴聚集物中的CD68+细胞,而是分散在整个组织中的CD68+细胞的一个特征。50%的组织浸润CD68+细胞合成72-kD IV型胶原酶。只有一小部分CD68+细胞既产生细胞因子又产生胶原酶,这表明炎症组织中CD68+细胞具有功能特化或不同的分化阶段。CD68+细胞的激活并不局限于组织浸润细胞。在未经治疗的巨细胞动脉炎患者60%-80%的循环单核细胞中发现了IL-6和IL-1β的表达,而胶原酶的产生仅限于组织巨噬细胞。大多数循环单核细胞产生IL-6和IL-1β是巨细胞动脉炎和风湿性多肌痛患者的共同特征,但在类风湿性关节炎患者中未发现。这些数据表明,巨细胞动脉炎有两个疾病组成部分,即血管壁的炎症反应和单核细胞的全身激活。全身单核细胞激活可以独立表现,无血管炎,如风湿性多肌痛患者所示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d9/295180/0aac5e53e521/jcinvest00021-0235-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d9/295180/2426bdb38544/jcinvest00021-0234-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d9/295180/0aac5e53e521/jcinvest00021-0235-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d9/295180/2426bdb38544/jcinvest00021-0234-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d9/295180/0aac5e53e521/jcinvest00021-0235-a.jpg

相似文献

1
Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.巨细胞动脉炎中组织浸润和循环CD68 +细胞的功能特征。该疾病两种成分的证据。
J Clin Invest. 1994 Sep;94(3):1134-40. doi: 10.1172/JCI117428.
2
Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.白细胞介素-6的产生增加与巨细胞动脉炎患者疾病相关缺血事件的较低发生率相关:白细胞介素-6的血管生成活性作为一种潜在的保护机制。
Circulation. 2003 May 20;107(19):2428-34. doi: 10.1161/01.CIR.0000066907.83923.32. Epub 2003 May 12.
3
Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛的治疗成功预测因子和糖皮质激素受体的表达。
J Rheumatol. 2009 Oct;36(10):2269-76. doi: 10.3899/jrheum.090075. Epub 2009 Aug 14.
4
Immunopathways in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中的免疫途径。
Autoimmun Rev. 2004 Jan;3(1):46-53. doi: 10.1016/S1568-9972(03)00064-8.
5
Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.促炎细胞因子(白细胞介素-1β、肿瘤坏死因子α和白细胞介素-6)的组织产生与巨细胞动脉炎中全身炎症反应的强度以及皮质类固醇需求相关。
Rheumatology (Oxford). 2004 Mar;43(3):294-301. doi: 10.1093/rheumatology/keh058. Epub 2003 Dec 16.
6
Functional and structural regression of the rabbit corpus luteum is associated with altered luteal immune cell phenotypes and cytokine expression patterns.兔黄体的功能和结构退化与黄体免疫细胞表型及细胞因子表达模式的改变有关。
Histochem Cell Biol. 2002 Dec;118(6):479-89. doi: 10.1007/s00418-002-0471-6. Epub 2002 Nov 27.
7
Giant cell vasculitis is a T cell-dependent disease.巨细胞血管炎是一种T细胞依赖性疾病。
Mol Med. 1997 Aug;3(8):530-43.
8
Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.风湿性多肌痛和巨细胞动脉炎患者的组织细胞因子模式。
Ann Intern Med. 1994 Oct 1;121(7):484-91. doi: 10.7326/0003-4819-121-7-199410010-00003.
9
Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.颞动脉炎中淋巴细胞和巨噬细胞亚群及其免疫激活标志物的免疫组织化学分析。皮质类固醇治疗的影响。
Arthritis Rheum. 1989 Jul;32(7):884-93.
10
Giant cell arteritis--a molecular approach to the multiple facets of the syndrome.巨细胞动脉炎——对该综合征多方面的分子学研究方法
Ann Med Interne (Paris). 1998 Nov;149(7):420-4.

引用本文的文献

1
Innate immunity in peripheral tissues is differentially impaired under normal and endotoxic conditions in aging.衰老过程中,在正常和内毒素条件下,外周组织的固有免疫会出现差异性功能障碍。
Front Immunol. 2024 Aug 16;15:1357444. doi: 10.3389/fimmu.2024.1357444. eCollection 2024.
2
Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling.巨细胞动脉炎的组织损伤的最新认识:从急性炎症反应到不适当的组织重塑。
Cells. 2024 Feb 29;13(5):430. doi: 10.3390/cells13050430.
3
Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice.

本文引用的文献

1
Pathogenesis of giant cell arteritis.巨细胞动脉炎的发病机制。
Arthritis Rheum. 1993 Jun;36(6):757-61. doi: 10.1002/art.1780360604.
2
The role of interleukin-1 in disease.白细胞介素-1在疾病中的作用。
N Engl J Med. 1993 Jan 14;328(2):106-13. doi: 10.1056/NEJM199301143280207.
3
Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune diseases.HLA-DR分子上的功能结构域:HLA-DR基因与不同自身免疫性疾病关联的意义。
巨细胞动脉炎:发病机制研究进展及其对临床实践的意义。
Cells. 2024 Jan 31;13(3):267. doi: 10.3390/cells13030267.
4
Exploring the causal role of gut microbiota in giant cell arteritis: a Mendelian randomization analysis with mediator insights.探讨巨细胞动脉炎中肠道微生物群的因果作用:中介物分析的孟德尔随机化分析。
Front Immunol. 2024 Jan 4;14:1280249. doi: 10.3389/fimmu.2023.1280249. eCollection 2023.
5
Association of Somatic TET2 Mutations With Giant Cell Arteritis.体细胞 TET2 突变与巨细胞动脉炎的关联。
Arthritis Rheumatol. 2024 Mar;76(3):438-443. doi: 10.1002/art.42738. Epub 2024 Feb 2.
6
Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors.生物靶向改善病情抗风湿药物和 Janus 激酶抑制剂治疗的巨细胞动脉炎患者的分子谱变化。
Front Immunol. 2023 May 1;14:1197342. doi: 10.3389/fimmu.2023.1197342. eCollection 2023.
7
Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis.巨细胞动脉炎患者单核细胞和 B 细胞的独特基因特征:一项纵向转录组分析。
Arthritis Res Ther. 2023 Jan 3;25(1):1. doi: 10.1186/s13075-022-02982-9.
8
Pathogenesis of giant cell arteritis with focus on cellular populations.巨细胞动脉炎的发病机制,重点关注细胞群体。
Front Med (Lausanne). 2022 Nov 17;9:1058600. doi: 10.3389/fmed.2022.1058600. eCollection 2022.
9
Pathogenic role of monocytes/macrophages in large vessel vasculitis.单核细胞/巨噬细胞在大血管血管炎中的致病作用。
Front Immunol. 2022 Jul 29;13:859502. doi: 10.3389/fimmu.2022.859502. eCollection 2022.
10
Vasculitogenic T Cells in Large Vessel Vasculitis.大动脉炎中的血管生成性 T 细胞。
Front Immunol. 2022 Jun 15;13:923582. doi: 10.3389/fimmu.2022.923582. eCollection 2022.
Clin Immunol Immunopathol. 1994 Feb;70(2):91-8. doi: 10.1006/clin.1994.1015.
4
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.风湿性多肌痛和巨细胞动脉炎中白细胞介素-6产生与疾病活动的相关性。
Arthritis Rheum. 1993 Sep;36(9):1286-94. doi: 10.1002/art.1780360913.
5
HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.风湿性多肌痛、巨细胞动脉炎和类风湿关节炎中的HLA - DRB1等位基因。
Arthritis Rheum. 1994 Apr;37(4):514-20. doi: 10.1002/art.1780370411.
6
Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.巨细胞动脉炎中不同的血管病变具有相同的T细胞克隆型。
J Exp Med. 1994 Mar 1;179(3):951-60. doi: 10.1084/jem.179.3.951.
7
Modulation of helper T cell function by prostaglandins.前列腺素对辅助性T细胞功能的调节
Arthritis Rheum. 1994 Jun;37(6):925-33. doi: 10.1002/art.1780370623.
8
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.风湿性多肌痛:一项为期10年的流行病学和临床研究。
Ann Intern Med. 1982 Nov;97(5):672-80. doi: 10.7326/0003-4819-97-5-672.
9
HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis.风湿性多肌痛和巨细胞动脉炎中的人类白细胞抗原-DR位点抗原
J Rheumatol. 1981 Nov-Dec;8(6):993-6.
10
Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis.风湿性多肌痛-巨细胞动脉炎中HLA-DR3和DR4频率增加。
Arthritis Rheum. 1983 Jul;26(7):925-7. doi: 10.1002/art.1780260717.